EP3723791
RECOMBINANT IGG FC MULTIMERS FOR THE TREATMENT OF NEUROMYELITIS OPTICA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.12.2018EP published:
21.2.2024EP application number:
18829780.8
EPO information:
European Patent Register
Max expiry date:
13.12.2038
Title in English:
RECOMBINANT IGG FC MULTIMERS FOR THE TREATMENT OF NEUROMYELITIS OPTICALanguage of the patent:
English
Timeline
Today
14.12.2018EP application
21.2.2024EP Publication
Owner
Name:
CSL Behring Lengnau AGAddress:
Biotech Innovation Park, 2543 Lengnau BE, CH
Name:
The Regents of the University of CaliforniaAddress:
1111 Franklin Street, 12th Floor, Oakland, CA 94607, US
Inventor
Name:
SPIRIG, RolfAddress:
3007 Bern, CH
Name:
BAZ MORELLI, AdrianaAddress:
Carlton, VIC 3053, AU
Name:
VERKMAN, AlanAddress:
San Francisco, CA 94127, US
Name:
TRADTRANTIP, LukmaneeAddress:
San Francisco, CA 94127, US
Priority
Number:
201762598592 PDate:
14.12.2017Country:
US
Number:
18168448Date:
20.4.2018Country:
EP
Classification
Categories:
A61K 39/00, C07K 16/28, C07K 16/46, A61K 47/68, A61P 37/06, C07K 16/00